Ambu A/S operates within the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ambu A/S with three other medical equipment manufacturers in Europe: Orthofix Medical Inc of the Netherlands (2018 sales of 384.50 million Euro [US$425.80 million] of which 43% was BioStim), Ypsomed Holding AG of Switzerland (466.12 million Swiss Francs [US$470.35 million] of which 68% was Delivery Devices), and Consort Medical Plc which is based in the United Kingdom (£311.10 million [US$387.42 million] of which 59% was Aesica).

Sales Analysis. During the year ended September of 2018, sales at Ambu A/S were 2.61 billion Danish Kroner (US$386.31 million). This is an increase of 10.7% versus 2017, when the company's sales were 2.36 billion Danish Kroner. This was the fifth consecutive year of sales increases at Ambu A/S (and since 2013, sales have increased a total of 88%). Sales of Visualisation saw an increase that was more than double the company's growth rate: sales were up 40.0% in 2018, from 597.00 million Danish Kroner to 836.00 million Danish Kroner.